Minerva Neurosciences Inc reports results for the quarter ended June 30 - Earnings Summary
I'm PortAI, I can summarize articles.
Minerva Neurosciences Inc reported a quarterly adjusted loss of 43 cents per share for the quarter ended June 30, an improvement from a loss of $1.09 in the same quarter last year. The reported revenue was zero, matching analyst expectations. The stock rose 4.4% this quarter but has lost 19.2% year-to-date. Analysts maintain a "hold" rating with no changes in earnings estimates over the last three months. The average recommendation for the biotechnology sector is "buy."
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments